Leber Congenital Amaurosis Therapeutic Pipeline Review H1 2015 Market Research Report
The report "Leber Congenital Amaurosis (LCA) – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Leber Congenital Amaurosis (LCA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.. Complete report on H1 2015 pipeline review of Leber Congenital Amaurosis (LCA) with 22 market data tables and 12 figures, spread across 52 pages...
View full press release